<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Aoki SK</submitter><funding>NIGMS NIH HHS</funding><pagination>323-40</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC2579741</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>70(2)</volume><pubmed_abstract>Contact-dependent growth inhibition (CDI) is a phenomenon by which bacterial cell growth is regulated by direct cell-to-cell contact via the CdiA/CdiB two-partner secretion system. Characterization of mutants resistant to CDI allowed us to identify BamA (YaeT) as the outer membrane receptor for CDI and AcrB as a potential downstream target. Notably, both BamA and AcrB are part of distinct multi-component machines. The Bam machine assembles outer membrane beta-barrel proteins into the outer membrane and the Acr machine exports small molecules into the extracellular milieu. We discovered that a mutation that reduces expression of BamA decreased binding of CDI+ inhibitor cells, measured by flow cytometry with fluorescently labelled bacteria. In addition, alpha-BamA antibodies, which recognized extracellular epitopes of BamA based on immunofluorescence, specifically blocked inhibitor-target cells binding and CDI. A second class of CDI-resistant mutants identified carried null mutations in the acrB gene. AcrB is an inner membrane component of a multidrug efflux pump that normally forms a cell envelope-spanning complex with the membrane fusion protein AcrA and the outer membrane protein TolC. Strikingly, the requirement for the BamA and AcrB proteins in CDI is independent of their multi-component machines, and thus their role in the CDI pathway may reflect novel, import-related functions.</pubmed_abstract><journal>Molecular microbiology</journal><pubmed_title>Contact-dependent growth inhibition requires the essential outer membrane protein BamA (YaeT) as the receptor and the inner membrane transport protein AcrB.</pubmed_title><pmcid>PMC2579741</pmcid><funding_grant_id>R01 GM034821</funding_grant_id><funding_grant_id>GM34821</funding_grant_id><funding_grant_id>R37 GM034821</funding_grant_id><funding_grant_id>R37 GM034821-24</funding_grant_id><pubmed_authors>Silhavy TJ</pubmed_authors><pubmed_authors>Thomas B</pubmed_authors><pubmed_authors>Trinh BN</pubmed_authors><pubmed_authors>Remers S</pubmed_authors><pubmed_authors>Jacoby K</pubmed_authors><pubmed_authors>Braaten BA</pubmed_authors><pubmed_authors>Malinverni JC</pubmed_authors><pubmed_authors>Pamma R</pubmed_authors><pubmed_authors>Webb J</pubmed_authors><pubmed_authors>Low DA</pubmed_authors><pubmed_authors>Aoki SK</pubmed_authors></additional><is_claimable>false</is_claimable><name>Contact-dependent growth inhibition requires the essential outer membrane protein BamA (YaeT) as the receptor and the inner membrane transport protein AcrB.</name><description>Contact-dependent growth inhibition (CDI) is a phenomenon by which bacterial cell growth is regulated by direct cell-to-cell contact via the CdiA/CdiB two-partner secretion system. Characterization of mutants resistant to CDI allowed us to identify BamA (YaeT) as the outer membrane receptor for CDI and AcrB as a potential downstream target. Notably, both BamA and AcrB are part of distinct multi-component machines. The Bam machine assembles outer membrane beta-barrel proteins into the outer membrane and the Acr machine exports small molecules into the extracellular milieu. We discovered that a mutation that reduces expression of BamA decreased binding of CDI+ inhibitor cells, measured by flow cytometry with fluorescently labelled bacteria. In addition, alpha-BamA antibodies, which recognized extracellular epitopes of BamA based on immunofluorescence, specifically blocked inhibitor-target cells binding and CDI. A second class of CDI-resistant mutants identified carried null mutations in the acrB gene. AcrB is an inner membrane component of a multidrug efflux pump that normally forms a cell envelope-spanning complex with the membrane fusion protein AcrA and the outer membrane protein TolC. Strikingly, the requirement for the BamA and AcrB proteins in CDI is independent of their multi-component machines, and thus their role in the CDI pathway may reflect novel, import-related functions.</description><dates><release>2008-01-01T00:00:00Z</release><publication>2008 Oct</publication><modification>2024-11-21T01:44:10.017Z</modification><creation>2019-03-27T00:19:16Z</creation></dates><accession>S-EPMC2579741</accession><cross_references><pubmed>18761695</pubmed><doi>10.1111/j.1365-2958.2008.06404.x</doi></cross_references></HashMap>